65岁以下患者生物瓣与机械瓣主动脉瓣置换术长期结局比较
该回顾性队列研究链接澳大利亚医院与死亡数据,纳入2003至2018年3969例主动脉瓣置换患者,按年龄分层(18-54岁;55-64岁),采用逆概率治疗加权比较生物瓣与机械瓣的死亡和再手术率。55-64岁患者中,生物瓣组10年以上死亡风险更高(HR 1.56;95%CI 1.01-2.42),再手术率在10年以上也更高(HR 2.87;95%CI 1.69-4.86);18-54岁患者再手术率在两个随访区间均更高。
要点
- 55-64岁患者生物瓣10年以上死亡风险高于机械瓣(HR 1.56;95%CI 1.01-2.42)。
- 55-64岁患者生物瓣10年以上再手术率高于机械瓣(HR 2.87;95%CI 1.69-4.86)。
- 18-54岁患者生物瓣再手术率在0-10年和10-15年均更高。
核心结论
- 55-64岁接受生物瓣的患者10年以上死亡风险更高。
- 整个队列中生物瓣植入者的再手术率更高。
- 有必要进一步研究生物瓣患者的长期结局。
- 持续长期监测生物瓣技术将确保循证决策和监管。
研究设计与样本
- 回顾性队列研究,使用澳大利亚链接的医院和死亡数据。
- 纳入2003至2018年间3969例主动脉瓣置换患者。
- 采用逆概率治疗加权队列比较瓣膜结局,按年龄分层(18-54岁;55-64岁)。
- 使用加权Cox回归模型估计风险比(HR),并使用加权累积发生率函数估计亚分布风险,随访区间为0至10年和10年以上至15年。
主要发现
- 55-64岁患者中,0-10年死亡率无差异。
- 55-64岁患者中,10年以上至15年生物瓣组死亡率更高(HR 1.56;95%CI 1.01-2.42)。
- 18-54岁患者中死亡率无差异。
- 55-64岁患者中,0-10年再手术率按瓣膜类型无差异,但10年以上至15年生物瓣高于机械瓣(HR 2.87;95%CI 1.69-4.86)。
- 18-54岁患者中,生物瓣再手术率在两个时间区间均更高(HR 2.54 [95%CI 1.03-6.25] 和 HR 4.48 [95%CI 2.15-9.32])。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The objectives of this study were to compare rates of mortality and reoperations for patients aged younger than 65 years who underwent surgical aortic valve replacement (AVR). AVR with a bioprosthetic valve (BV) is increasing among younger patients, however evidence to inform the choice between BV or mechanical valve is limited. METHODS: We performed a retrospective cohort study using linked hospital and mortality data from Australia, for 3969 AVR patients between 2003 and 2018. We compared outcomes for valves in inverse probability of treatment-weighted cohorts, stratified according to age (18-54 years; 55-64 years). We used weighted Cox regression models to estimate hazard ratios (HRs) and weighted cumulative incidence function for subdistribution hazards, for follow-up intervals: 0 to 10 and >10 to 15 years. RESULTS: Among patients aged 55 to 64 years, there was no difference in mortality at 0 to 10 years. However, at >10 to 15 years, mortality was higher among BV recipients (HR, 1.56; 95% CI, 1.01-2.42). There was no difference among patients aged 18 to 54 years. Reoperation rates for patients aged 55 to 64 years did not differ according to valve type at 0 to 10 years, but were higher for BV than mechanical valve at >10 to 15 years (HR, 2.87; 95% CI, 1.69-4.86). For patients aged 18 to 54 years, reoperation rates were consistently higher for BV at both time intervals (HR, 2.54 [95% CI, 1.03-6.25] and HR, 4.48 [95% CI, 2.15-9.32], respectively). CONCLUSIONS: Patients aged 55 to 64 years who received a BV had a higher risk of mortality beyond 10 years. Rates of reoperations were higher among patients implanted with a BV in the entire cohort. Further investigation of long-term outcomes among patients with a BV is necessary. Continuous long-term monitoring of BV technologies will ensure evidence-based decision-making and regulation.
引用
- Sotade OT, Falster MO, Pearson SA, et al. Comparison of long-term outcomes of bioprosthetic and mechanical aortic valve replacement in patients younger than 65 years. J Thorac Cardiovasc Surg. 2022. PMID: 35216820. doi:10.1016/j.jtcvs.2022.01.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。